AG Paxton Sues Big Pharma for 1,000% Insulin Price Hike Conspiracy

Translate to Spanish or other 102 languages!

 Texas Attorney General Ken Paxton sued major insulin manufacturers and pharmacy benefit managers (“PBMs”)—including Eli Lilly, Express Scripts, CVS Pharmacy, and others—over a conspiracy to increase prices of insulin. Image for illustration purposes
 Texas Attorney General Ken Paxton sued major insulin manufacturers and pharmacy benefit managers (“PBMs”)—including Eli Lilly, Express Scripts, CVS Pharmacy, and others—over a conspiracy to increase prices of insulin. Image for illustration purposes
- Advertisement -

AUSTIN – Texas Attorney General Ken Paxton sued major insulin manufacturers and pharmacy benefit managers (“PBMs”)—including Eli Lilly, Express Scripts, CVS Pharmacy, and others—over a conspiracy to increase prices of insulin.

Through this conspiracy, the manufacturers artificially and willingly raised the prices of insulin then paid a significant, undisclosed portion back to the PBMs as a quid pro quo for inclusion in the PBMs’ standard offerings. The PBMs then granted preferred status to the manufacturer whose drug has the highest list price while excluding lower priced drugs. These synthetic insulin drugs, which today cost the manufacturers less than $2 to produce and were originally priced at $20 when released in the late 1990s, now range between $300 and $700. In the last decade alone, the manufacturers who are defendants in the lawsuit have increased the prices of their insulins up to 1,000%. Attorney General Paxton is suing because the insulin pricing scheme violates the Texas Deceptive Trade Practices Act, constitutes unjust enrichment, and represents an unlawful civil conspiracy.

“This is a disturbing conspiracy by which pharmaceutical companies were intentionally and artificially inflating the price of insulin. Big Pharma insulin manufacturers and PBMs worked together to take advantage of diabetes patients and drive prices as high as they could,” said Attorney General Paxton. “These companies acted illegally and unethically to enrich themselves, and we will hold them accountable.”

- Advertisement -

According to the complaint, “While the PBM Defendants represent that they perform their services on behalf of their clients (including Texas payors) and diabetics to lower drug prices, increase access to affordable drugs, and promote diabetic health, these representations are false. Rather, the PBM Defendants have worked in coordination with the Manufacturer Defendants to distort the market for diabetic treatments to their benefit at the expense of Texas diabetics and payors.”

Liston & Deas, David Nutt & Associates, the Cicala Law Firm, and Foreman Watkins Krutz are serving as outside counsel.

To read the filing, click here.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Hispanics Face Higher Risk of Early Dementia, UT Health Study Finds

A form of dementia that strikes younger people is more common in Hispanics than previously thought, according to a new study led by researchers at UT Health San Antonio, the academic health center of The University of Texas at San Antonio.

Best Foods for Brain Health

 If you’re looking for ways to improve your brain health, it’s important to pay attention to your diet. But how do you know which one is best?

Why Spending Time in the Sun Drains Your Energy

Feeling drained after spending time outside in the sun? A Cleveland Clinic doctor explains why we often feel tired after soaking up the summer sunshine.

TSC’s Medical Aesthetics Information Session, July 30th

Texas Southmost College will host an information session for licensed health care professionals interested in expanding their skills through the college’s new Medical Aesthetics Injector Certificate program.
- Advertisement -